VYNE Therapeutics Inc. Common Stock
VYNE •
Buy Open
Signal type
Buy
Status
Open
Open Price
$0.75
Stop Loss
$0.37
Performance
-16.95%
Days Open
119
Signal Setup
Signal Type Buy
Status Open
Open Date Dec 17, 2025
Open Price $0.75
Stop Loss $0.37
Timespan Day
Company Profile
Name VYNE Therapeutics Inc. Common Stock
Ticker VYNE
Market Cap $27.50M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $0.62
List Date Jan 25, 2018
Description
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
Website Open Company Website